The IlluminOss® photodynamic bone stabilization system for pathological osteolyses and fractures of the humerus: indications, advantages and limits in a series of 12 patients at 24 months of minimum follow-up.


Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
11 Jan 2021
Historique:
received: 02 04 2020
accepted: 26 12 2020
entrez: 12 1 2021
pubmed: 13 1 2021
medline: 15 5 2021
Statut: epublish

Résumé

Locked titanium nails are considered the reference treatment for metastatic bone lesions of the humerus in patients with aggressive histotypes, high risk of fracture or when estimated survival is lower than 6 months.Nevertheless, they are responsible for CT and MRI artifacts which interfere with postoperative radiotherapy and follow-up.The IlluminOss® is an intramedullary stabilization system which is introduced inside the humeral canal in a deflated state, and is then distended with a monomer which hardens after exposure to blue light,stabilizing the segment; it does not cause artifacts, allowing easier and more effective radiotherapy and follow-up. The aim of this study is to report our experience, indications, possible advantages and limitations of this stabilization system at 24 months of minimum follow-up in a series of 12 patients affected by pathological fractures or impending fractures of the humerus. This is a retrospective case-series that included all patients who underwent surgery with the IlluminOss® Photodynamic Bone Stabilization System for pathological osteolyses and fractures of the humerus. Intraoperative and postoperative complications were valued. 12 patients and 13 procedures were included in the study. All surgeries were performed without intraoperative complications. No early postoperative complications were noted. The wounds healed in all cases and stitches were removed at two weeks from surgery, so the patients were able to perform chemotherapy after three weeks. All patients except one had a painless active range of motion which reached 90°.The VAS score was 7 preoperatively and 2.6 at one month from surgery. Pain relief was also associated to radiotherapy and chemotherapy. Unfortunately, two nail ruptures were reported at 4 and 12 months of follow-up. No artifacts were noted in the postoperative CT scans so the radiotherapy plans were easily performed without the need of dose compensation. The IlluminOss® intramedullary stabilization system can provide primary stability in humeral fractures and impending fractures;the surgical technique is easy and minimally invasive.Moreover,it does not present artifacts at postoperative imaging,probably giving a better chance to perform prompt radiotherapy and chemotherapy.However, randomized clinical studies are necessary to verify its potential strength and if precocious adjuvant radio- and chemotherapy are associated to a reduction of the local progression rate.

Sections du résumé

BACKGROUND BACKGROUND
Locked titanium nails are considered the reference treatment for metastatic bone lesions of the humerus in patients with aggressive histotypes, high risk of fracture or when estimated survival is lower than 6 months.Nevertheless, they are responsible for CT and MRI artifacts which interfere with postoperative radiotherapy and follow-up.The IlluminOss® is an intramedullary stabilization system which is introduced inside the humeral canal in a deflated state, and is then distended with a monomer which hardens after exposure to blue light,stabilizing the segment; it does not cause artifacts, allowing easier and more effective radiotherapy and follow-up. The aim of this study is to report our experience, indications, possible advantages and limitations of this stabilization system at 24 months of minimum follow-up in a series of 12 patients affected by pathological fractures or impending fractures of the humerus.
METHODS METHODS
This is a retrospective case-series that included all patients who underwent surgery with the IlluminOss® Photodynamic Bone Stabilization System for pathological osteolyses and fractures of the humerus. Intraoperative and postoperative complications were valued.
RESULTS RESULTS
12 patients and 13 procedures were included in the study. All surgeries were performed without intraoperative complications. No early postoperative complications were noted. The wounds healed in all cases and stitches were removed at two weeks from surgery, so the patients were able to perform chemotherapy after three weeks. All patients except one had a painless active range of motion which reached 90°.The VAS score was 7 preoperatively and 2.6 at one month from surgery. Pain relief was also associated to radiotherapy and chemotherapy. Unfortunately, two nail ruptures were reported at 4 and 12 months of follow-up. No artifacts were noted in the postoperative CT scans so the radiotherapy plans were easily performed without the need of dose compensation.
CONCLUSIONS CONCLUSIONS
The IlluminOss® intramedullary stabilization system can provide primary stability in humeral fractures and impending fractures;the surgical technique is easy and minimally invasive.Moreover,it does not present artifacts at postoperative imaging,probably giving a better chance to perform prompt radiotherapy and chemotherapy.However, randomized clinical studies are necessary to verify its potential strength and if precocious adjuvant radio- and chemotherapy are associated to a reduction of the local progression rate.

Identifiants

pubmed: 33430839
doi: 10.1186/s12891-020-03927-6
pii: 10.1186/s12891-020-03927-6
pmc: PMC7798276
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

63

Références

Eur J Orthop Surg Traumatol. 2017 Feb;27(2):205-211
pubmed: 27650452
Medicine (Baltimore). 2019 Sep;98(37):e16936
pubmed: 31517814
J Orthop Surg Res. 2019 Aug 30;14(1):285
pubmed: 31470878
J Orthop Surg (Hong Kong). 2003 Jun;11(1):34-7
pubmed: 12810969
Int J Clin Oncol. 2012 Aug;17(4):417-21
pubmed: 21915771
J Bone Jt Infect. 2019 Sep 18;4(5):216-222
pubmed: 31700769
Injury. 2017 Oct;48 Suppl 3:S55-S59
pubmed: 29025611
J Orthop Res. 2017 Oct;35(10):2181-2190
pubmed: 28135014
J Surg Orthop Adv. 2018 Fall;27(3):178-186
pubmed: 30489242
Rev Esp Cir Ortop Traumatol. 2018 May - Jun;62(3):185-189
pubmed: 29574162
J Surg Oncol. 2014 Sep;110(4):360-5
pubmed: 24889389
Clin Orthop Relat Res. 1993 Jan;(286):241-6
pubmed: 8425352
Acta Biomed. 2020 Sep 07;91(3):e2020057
pubmed: 32921754
Ann Chir Gynaecol. 1998;87(4):321-4
pubmed: 9891774
Acta Orthop Belg. 2001 Dec;67(5):456-63
pubmed: 11822075
Clin Orthop Relat Res. 1989 Dec;(249):256-64
pubmed: 2684463
Injury. 2020 Apr;51(4):947-954
pubmed: 32143857
Orthop Rev (Pavia). 2017 Feb 20;9(1):6988
pubmed: 28286623
Radiol Med. 2019 Jan;124(1):34-49
pubmed: 30191448
Eur J Surg Oncol. 1996 Dec;22(6):621-6
pubmed: 9005151
Acta Orthop Belg. 2012 Aug;78(4):523-30
pubmed: 23019787
Skeletal Radiol. 2015 Sep;44(9):1317-25
pubmed: 25982252
J Orthop. 2016 Jul 06;13(4):343-6
pubmed: 27436924

Auteurs

Carmine Zoccali (C)

Oncological Orthopaedics Department, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. carminezoccali@libero.it.

Dario Attala (D)

Oncological Orthopaedics Department, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.

Mattia Pugliese (M)

Orthopedics and Traumatology School, Department of Surgery, Sapienza University of Rome, Piazzale Aldo Moro 3/5, 00100, Rome, Italy.

Alessandra Scotto di Uccio (AS)

School of General Surgery, Hepatobiliary Surgery and Organ Transplant Unit, Department of Surgery, Sapienza University of Rome, Piazzale Aldo Moro 3/5, 00100, Rome, Italy.

Jacopo Baldi (J)

Oncological Orthopaedics Department, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH